
Shares of Immuron IMC.AX rise 26.2% to A$0.082, their highest since February 28
Biopharmaceutical co reports FY25 global annual sales of A$7.3 million ($4.75 million), up 49% on y-o-y
"In FY26, we will invest to grow in North America" - co
Stock on track for best day since March 2024
About 1.1 mln shares change hands, 15.1x the 30-day average of 70,880; busiest session since January 17
Stock up 2.5% YTD, including moves in the current session
($1 = 1.5368 Australian dollars)